Year 2009 / Volume 101 / Number 11
Puntos De Vista
Noninvasive assessment of liver fibrosis. Serum markers and transient elastography (FibroScan)

pp. 787-799

Marín Gabriel, J. C. / Solís Herruzo, J. A.

Abstract
Both the prognosis and potential treatment of chronic liver disease greatly depend on the progression of liver fibrosis, which is the ultimate outcome of chronic liver damage. Historically, liver biopsy has been instrumental in adequately assessing patients with chronic liver disease. Histological assessment allows clinicians both to obtain diagnostic information and initiate adequate therapy. However, the technique is not exempt of deleterious effects. Multiple diagnostic tests have been developed for the staging of fibrosis using noninvasive methods, most of them in the setting of chronic hepatitis C. The goal of this paper is to review available data on the staging and assessment of liver fibrosis with two methods: serum markers and transient elastography (FibroScan®).
Share Button
New comment
Comments
No comments for this article
Related articles
Citation tools
Marín Gabriel, J. C. / Solís Herruzo, J. A.. Noninvasive assessment of liver fibrosis. Serum markers and transient elastography (FibroScan). 787-799


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 885 visits.
This article has been downloaded 21 times.
Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology